Maire N - Search Results

1

Modeling the public health impact of malaria vaccines for developers and policymakers.

Nunes JK, Cárdenas V, Loucq C, Maire N, Smith T, Shaffer C, Måseide K, Brooks A. Nunes JK, et al. Among authors: maire n. BMC Infect Dis. 2013 Jul 1;13:295. doi: 10.1186/1471-2334-13-295. BMC Infect Dis. 2013. PMID: 23815273 Free PMC article.

2

Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine.

Smith T, Ross A, Maire N, Chitnis N, Studer A, Hardy D, Brooks A, Penny M, Tanner M. Smith T, et al. Among authors: maire n. PLoS Med. 2012 Jan;9(1):e1001157. doi: 10.1371/journal.pmed.1001157. Epub 2012 Jan 17. PLoS Med. 2012. PMID: 22272189 Free PMC article.

3

What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines.

Penny MA, Maire N, Studer A, Schapira A, Smith TA. Penny MA, et al. Among authors: maire n. PLoS One. 2008 Sep 11;3(9):e3193. doi: 10.1371/journal.pone.0003193. PLoS One. 2008. PMID: 18784833 Free PMC article.

4

Simulation of the cost-effectiveness of malaria vaccines.

Tediosi F, Maire N, Penny M, Studer A, Smith TA. Tediosi F, et al. Among authors: maire n. Malar J. 2009 Jun 8;8:127. doi: 10.1186/1475-2875-8-127. Malar J. 2009. PMID: 19505328 Free PMC article.

5

Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview.

Smith T, Killeen GF, Maire N, Ross A, Molineaux L, Tediosi F, Hutton G, Utzinger J, Dietz K, Tanner M. Smith T, et al. Among authors: maire n. Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):1-10. doi: 10.4269/ajtmh.2006.75.2_suppl.0750001. Am J Trop Med Hyg. 2006. PMID: 16931810

6

Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa.

Maire N, Tediosi F, Ross A, Smith T. Maire N, et al. Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):111-8. doi: 10.4269/ajtmh.2006.75.111. Am J Trop Med Hyg. 2006. PMID: 16931822

7

A research agenda for malaria eradication: modeling.

malERA Consultative Group on Modeling. malERA Consultative Group on Modeling. PLoS Med. 2011 Jan 25;8(1):e1000403. doi: 10.1371/journal.pmed.1000403. PLoS Med. 2011. PMID: 21283605 Free PMC article. Review.

8

Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.

Ross A, Maire N, Sicuri E, Smith T, Conteh L. Ross A, et al. Among authors: maire n. PLoS One. 2011 Apr 7;6(4):e18391. doi: 10.1371/journal.pone.0018391. PLoS One. 2011. PMID: 21490967 Free PMC article.

9

Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria.

Maire N, Shillcutt SD, Walker DG, Tediosi F, Smith TA. Maire N, et al. Value Health. 2011 Dec;14(8):1028-38. doi: 10.1016/j.jval.2011.06.004. Epub 2011 Aug 15. Value Health. 2011. PMID: 22152171 Free article.

10

Modeling a field trial of the RTS,S/AS02A malaria vaccine.

Maire N, Aponte JJ, Ross A, Thompson R, Alonso P, Utzinger J, Tanner M, Smith T. Maire N, et al. Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):104-10. doi: 10.4269/ajtmh.2006.75.104. Am J Trop Med Hyg. 2006. PMID: 16931821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page